Editors' note: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Ganesh A, Galetta S. Neurology 2020;94:593.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ganesh A, Galetta S. Editors' note: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology 2020;94:593.
PMID: 32229634